You might be saying to yourself well that’s wonderful  a new insulin pump sensor has received FDA approval.  But what does that have to do with the eyes or vision? High blood sugar causes the lens of the eye to swell, which changes your ability to see. When your blood glucose (sugar) levels go up, fluid enters the lens of your eyes and when your blood glucose goes down, the fluid shifts out of your lens. These changes in the fluid in the lens cause blurred vision, so both high and low blood glucose levels affect your vision.  As your blood glucose levels stabilize on insulin, these shifts become less and your vision improves. -MDA
by: Miriam E Tucker
The US Food and Drug Administration (FDA) has approved the Animas Vibe insulin pump and continuous glucose monitor (CGM) system for the management of insulin-requiring diabetes in adults aged 18 years and older.
The new product incorporates the Dexcom G4 Platinum CGM technology, allowing users to read glucose monitor data from the pump screen itself, rather than requiring a separate device.
Other features of the Animas Vibe will enable precise insulin dosing with a low basal increment, ranging from 0.025 to 25.0 units per hour, and bolus increments starting at 0.05 and going up to 35.00 units per bolus.
Users can customize dosing, as the device allows for up to 12 personalized settings of insulin-to-carb ratios, insulin-sensitivity (“correction”) factors, and blood glucose targets in 30-minute increments. It is waterproof up to 12 ft for 24 hours.
The Dexcom CGM is approved for up to 7 days of continuous wear, with a mean absolute relative difference — the percentage of data points above or below a laboratory reference standard for blood glucose — of 13%. The transmitter is water resistant up to 8 ft for 24 hours.
The Animas Vibe system also allows for customizable alarms to indicate high or low glucose levels…….
Read more:
Source: Medscape